2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings
Author:
Revell Andrew D1, Wang Dechao1, Perez-Elias Maria-Jesus2ORCID, Wood Robin3, Cogill Dolphina3, Tempelman Hugo4, Hamers Raph L5ORCID, Reiss Peter56, van Sighem Ard6, Rehm Catherine A7, Agan Brian8, Alvarez-Uria Gerardo9, Montaner Julio S G10, Lane H Clifford7, Larder Brendan A1, Reiss Peter, van Sighem Ard, Montaner Julio, Harrigan Richard, de Wit Tobias Rinke, Hamers Raph, Sigaloff Kim, Agan Brian, Marconi Vincent, Wegner Scott, Sugiura Wataru, Zazzi Maurizio, Kaiser Rolf, Schuelter Eugen, Streinu-Cercel Adrian, Alvarez-Uria Gerardo, Garcia Federico, de Oliveira Tulio, Gatell Jose, Lazzari Elisa, Gazzard Brian, Nelson Mark, Pozniak Anton, Mandalia Sundhiya, Smith Colette, Ruiz Lidia, Clotet Bonaventura, Staszewski Schlomo, Torti Carlo, Lane Cliff, Metcalf Julie, Rehm Catherine A, Perez-Elias Maria-Jesus, Vella Stefano, Dettorre Gabrielle, Carr Andrew, Norris Richard, Hesse Karl, Vlahakis Emanuel, Tempelman Hugo, Barth Roos, Wood Robin, Morrow Carl, Cogill Dolphina, Hoffmann Chris, Ene Luminita, Dragovic Gordana, Diaz Ricardo, Sucupira Cecilia, Sued Omar, Cesar Carina, Madero Juan Sierra, Balakrishnan Pachamuthu, Saravanan Shanmugam, Emery Sean, Cooper David, Torti Carlo, Baxter John, Monno Laura, Torti Carlo, Gatell Jose, Clotet Bonventura, Picchio Gaston, deBethune Marie-Pierre, Perez-Elias Maria-Jesus, Emery Sean, Khabo Paul, Ledwaba Lotty,
Affiliation:
1. The HIV Resistance Response Database Initiative (RDI), London, UK 2. Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain 3. Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa 4. Ndlovu Care Group, Elandsdoorn, South Africa 5. Departments of Internal Medicine and Global Health, Academic Medical Centre of the University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands 6. Stichting HIV Monitoring, Amsterdam, The Netherlands 7. National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA 8. Uniformed Services University of the Health Sciences and Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA 9. Rural Development Trust (RDT) Hospital, Bathalapalli, India 10. BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
Abstract
Abstract
Objectives
With the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately in the absence of commonly used baseline data.
Methods
Twelve sets of random forest models were trained using very large, global datasets to predict either the probability of virological response (classifier models) or the absolute change in viral load in response to a new regimen (absolute models) following virological failure. Two ‘standard’ models were developed with all baseline variables present and 10 others developed without HIV genotype, time on therapy, CD4 count or any combination of the above.
Results
The standard classifier models achieved an AUC of 0.89 in cross-validation and independent testing. Models with missing variables achieved AUC values of 0.78–0.90. The standard absolute models made predictions that correlated significantly with observed changes in viral load with a mean absolute error of 0.65 log10 copies HIV RNA/mL in cross-validation and 0.69 log10 copies HIV RNA/mL in independent testing. Models with missing variables achieved values of 0.65–0.75 log10 copies HIV RNA/mL. All models identified alternative regimens that were predicted to be effective for the vast majority of cases where the new regimen prescribed in the clinic failed. All models were significantly better predictors of treatment response than genotyping with rules-based interpretation.
Conclusions
These latest models that predict treatment responses accurately, even when a number of baseline variables are not available, are a major advance with greatly enhanced potential benefit, particularly in resource-limited settings. The only obstacle to realizing this potential is the willingness of healthcare professions to use the system.
Funder
National Cancer Institute National Institutes of Health Department of Health and Human Services U.S. Government
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|